Offer Products
Face Care
Hair Care
stationery & office
Tea & Coffee
Baby Wipes
Cream
Baby Essentials
Fragrances
Lip Care
Body Care
Air Freshener
General Actions (Not specific medical benefits for the user)
| Core Action | Mechanism |
| Increases Glucose Excretion (Empagliflozin) | Empagliflozin inhibits the Sodium-Glucose Co-Transporter 2 (SGLT2) in the kidneys, leading to increased excretion of glucose in the urine and thus lowering blood sugar levels independently of insulin. |
| Reduces Hepatic Glucose Production (Metformin) | Metformin works primarily by decreasing glucose production in the liver and improving the body's sensitivity to insulin in muscle and fat tissue. |
| Cardiovascular Protection | Empagliflozin has demonstrated significant benefits in reducing the risk of cardiovascular death and hospitalization for heart failure in patients with established cardiovascular disease. |
| Promotes Weight Reduction | Due to the loss of calories via glucose excreted in the urine, the Empagliflozin component often contributes to modest weight loss, which is beneficial for Type 2 Diabetes management. |
⚠️ Important Safety Note:
Empaglif-M 5/500mg Tablet is a prescription medication.
Warning! You must be logged in to submit a review.
Login
Customer questions & answers
Customer reviews
0 out of 5